Senior Healthcare Reporter for @BLAW [email protected] Signal: sandhyawrites.30 // Talk to me about policy and paw-licy. 🏛️🐶

Washington DC
Joined April 2011
Sandhya Raman retweeted
New: FDA leadership is kicking off a top-to-bottom review of how it approaches approvals for drugs to treat rare diseases. The Rare Disease Framework Initiative will kick off with a meeting on Oct. 28 w/ @RobertLangreth 🎁: bloomberg.com/news/articles/…
4
23
2
63
7,524
First in @BLaw: The leading hospital trade association is challenging the government’s renewed attempt at a 340B drug rebate pilot slated to run early next year, seeking to derail the new discount mechanism for the second time. news.bloomberglaw.com/health…
6
1
6
999
A three-judge panel mulled Tuesday what authority it has to review RFK Jr.'s appointments to a federal vaccine advisory panel, weighing whether it will overturn an order suspending the hand-picked selections. news.bloomberglaw.com/health…
1
5
370
Sandhya Raman retweeted
New: Likely Louisiana senator-to-be Julia Letlow is already thinking about her health priorities for 2027, which include implementing a universal breast cancer risk assessment. It’s personal for Letlow, who shared she had a double mastectomy 3 years ago. news.bgov.com/bloomberg-gove…
1
10
9
2,754
Sandhya Raman retweeted
Update with new details: The Monday rollout of RFK Jr's new vaccine injury initiative included: -Ribbon cutting of a new NIH clinic focused on vaccine injured people -A proposal to pay doctors for reporting vaccine injuries -Modernizing the agency's vaccine adverse event reporting system -New requirements around electronic health records bloomberg.com/news/articles/…
13
25
1
74
4,932
Sandhya Raman retweeted
Florida Attorney General James Uthmeier filed a lawsuit against Pfizer Inc. alleging the drug company and its chief executive misled individuals about the safety of its Covid-19 vaccine. news.bloomberglaw.com/health…
2
1,230
Sandhya Raman retweeted
"The fix is in": The end of the fiscal year is crunch time to get federal dollars out the door, and the administration’s penchant for testing the limits of federal spending law gives lawmakers reason to worry the money may expire. w/ @SandhyaWrites news.bgov.com/bloomberg-gove…
1
462
Sandhya Raman retweeted
New: @cecelou18 and I dug into the 80+ new hires at the Justice Department's civil rights division, which has pivoted its focus under Trump. Some come from conservative advocacy & GOP politics. Two new lawyers are facing bar disciplinary proceedings. news.bloomberglaw.com/us-law…
1
6
4
820
Sandhya Raman retweeted
Really important work analyzing new prior authorization data by my colleagues @jtozz @tanaz115 + @ikeswetlitz. Patients won about half of the time they appealed health insurance denials. For some plans, patients won their appeals around 90% of the time. 🎁: bloomberg.com/news/features/…
2
18
2
24
3,649
Sandhya Raman retweeted
Food sector stakeholders are duking it out with public health advocates at the White House over a forthcoming definition of ultra-processed foods. Companies argue it could create new legal risks, while health experts call it a key step toward regulation: news.bloomberglaw.com/health…
1
3
122
Sandhya Raman retweeted
Agencies are moving to give political appointees a bigger say in how grant money goes out the door, even as Congress has stalled the White House’s efforts to expand such authorities across the federal government. news.bgov.com/bloomberg-gove…
1
391
Sandhya Raman retweeted
New investigation from me: Schools are considering how to serve students with specific health needs as Medicaid cuts roll in. In Indiana, which has led states in disenrolling Medicaid/CHIP coverage, school districts are considering what is at stake. news.bgov.com/bloomberg-gove…
10
4
814
Sandhya Raman retweeted
The Department of Defense is attempting to redirect National Institute of Health money to bolster the Pentagon’s budget, according to the top Democrat on the House Appropriations Committee. news.bgov.com/bloomberg-gove…
5
51
6
69
25,982
Altria is challenging FDA’s tobacco product review process. "The aim of this lawsuit is to end the dysfunction caused by a regulator that cannot do the job the TCA requires, in the time the statute requires the agency to do it," the complaint said. news.bloomberglaw.com/health…
1
4
6
480